Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics posted a gain of 10 percent on more than three-times the average daily volume Tuesday. The company has recently reported that the FDA has approved their investigational new drug application for ICT-140, a treatment for ovarian cancer.
Going forward ... (see research report)
Subscribe to News Feeds